Indispensable to routine and esoteric clinical diagnostics, immunoassays are featured alongside clinical chemistry in highly automated integrated chemistry stations through manually intensive, wet enzyme immunoassay (EIA) plates for specialty infectious disease and autoimmune testing. Immunoassays are also used throughout the world for serological screening of donated blood and plasma. Recent reports from Kalorama Information offer market insights into immunoassay applications for autoimmune, infectious disease, and blood bank testing worldwide.
- Display 30 Products per page
Published: April 7, 2020 | Price: $4,000.00 – $8,000.00
The past few years has seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market and many more are in development. In recent years, diagnostics companies – in collaboration with AI companies – have begun implementing increasingly sophisticated machine learning techniques to improve the power of data analysis for patient care. The goal is to use developed algorithms to standardize and aid interpretation of...Published: October 11, 2016 | Price: $3,360.00 – $6,720.00
Autoimmune IVD Testing Market This report provides important business planning information for in vitro diagnostic testing products, instruments and supplies used in the detection of autoimmune disease. The report includes market sizing and forecasts, regional markets, markets by type - including arthritis, thyroid, gastrological disease, SLE, and others. The report also details new innovations in testing and profiles companies in the market. The following companies are covered. Revenues, test product, and significant competitive moves are included: Thermo Fisher WerfenLife, Alere,...Published: April 20, 2016 | Price: $2,000.00 – $4,000.00
Blood Testing Market in China (Typing, Immunoassay, NAT Testing) With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. Blood Testing Market in China offers the most current look at the blood testing IVD market in China, including tests for blood typing, immunoassay-based tests and NAT Tests. The report provides market analysis and data on the blood testing market environment in China, including: Blood...Published: June 16, 2017 | Price: $2,800.00 – $5,600.00
Brazil IVD Market Analysis Brazil IVD Market Analysis provides useful information to business planners including market size estimates for various segments, forecasts, competitive analysis, corporate profiles, market share and other information on the Brazilian laboratory market and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of market segments, including: Brazil IVD Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay, Microbiology/Molecular, POC, Histology, Other, Total) Brazil IVD Sales by Market Segment, 2016 Market Distribution...Published: August 15, 2012 | Price: $995.00 – $1,995.00
Mobile health has reached in vitro diagnostics and as this Kalorama report details, may change the industry forever. Over the years, the introduction of transportable, portable, and handheld instruments has resulted in the migration of clinical lab testing from the central lab to a range of environments including self-testing, community clinics, the workplace, home, disaster care and most recently, retail convenience clinics. In spite of promotional materials that emphasize ease of use, the majority of currently available POC tests require...Published: November 1, 2007 | Price: $1,995.00 – $3,990.00
No longer is cell-based diagnostics simply a histological study of biopsied and surgical tissues. Combinations of tests and technologies are coming together to create a new map of cell diagnostics. Image cytometry, microfluidics, microarrays, and biosensors, special immunohistochemical and in situ hybridization probes are creating new approaches to cell and tissue observation, diagnostics and pharmacogenomics. This report covers assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood,...Published: January 1, 2005 | Price: $3,500.00 – $7,000.00
This report covers clinical and drug discovery assay systems that use cells as the basic source material. Sources of the cells to be studied include peripheral blood, cord blood, bone marrow, urine, cerebrospinal and other body fluids and tissue samples. Cell analysis is not a new laboratory procedure. Clinical diagnostics using cells and tissues is one of the oldest disciplines in laboratory medicine. Histological study of biopsy samples, the complete blood count, and the enumeration of disease-bearing cells have been...Published: December 1, 2006 | Price: $4,500.00 – $9,990.00
The current population of India is 1.065 billion, and with a growth rate of 1.7%, India will surpass China to become the world’s largest country around 2030. For diagnostic manufacturers, this enormous market is just now being recognized as a high-growth area as the pace of economic growth in India accelerates and modern laboratory practices become established. This comprehensive report on the market for clinical in vitro diagnostic (IVD) tests in India covers both reagent and instrumentation markets for the...Published: March 8, 2019 | Price: $5,000.00 – $10,000.00
Clinical laboratories are an essential part of the health industry. It is estimated that between 70% - 80% of physicians’ diagnoses are a result of laboratory tests. In addition to diagnosing patients, clinical lab testing is performed to evaluate disease progression, monitor drug treatment and conditions, determine individual therapy, and several other reasons. Clinical Laboratory Services Market provides an overview of the clinical laboratory industry and the trends driving growth. Included in the report are statistics influencing the industry, incidence...Published: January 27, 2020 | Price: $4,750.00 – $9,500.00
Clinical laboratories are an essential part of the health industry. The market for laboratory services ranges from routine blood work to esoteric laboratory-developed tests (LDTs). In addition to diagnosing patients, clinical lab testing may be performed to evaluate disease progression, to monitor drug treatment and conditions, and to determine individual therapy. Kalorama’s Clinical Laboratory Services Market, 5th Edition, examines the world and regional markets and is essential for laboratory and IVD companies seeking to better understand the market potential. The...Published: June 8, 2021 | Price: $4,000.00 – $8,000.00
Clinical Laboratory Services Market, 6th Edition, new from Kalorama Information, provides an overview of the clinical laboratory industry and the trends driving growth. Included in the report are statistics influencing the industry, incidence of diseases in the U.S. and worldwide demographics, life expectancy, and company strategies. Information is presented as a global focused market report, with key regions discussed including: North America (United States, Canada) Europe, Middle East, and Africa - EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland) Asia...Published: June 28, 2022 | Price: $6,000.00 – $12,000.00
Clinical Laboratory Services Market, 7th Edition provides an overview of the clinical laboratory industry and the trends driving growth. Included in the report are statistics influencing the industry, incidence of diseases in the U.S. and worldwide demographics, life expectancy, and company strategies. Information is presented as a global focused market report, with key regions discussed including: North America (United States, Canada) Europe, Middle East, and Africa - EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland) Asia Pacific (Japan, China, India,...Published: May 16, 2023 | Price: $5,000.00 – $10,000.00
Your Resource for Business Planning in the Clinical Laboratory Market What's the size of the service market for clinical testing? What type of tests are selling? Where is this market going next five years? Which companies will earn those revenues? Where is growth coming from? How will LDT regulation affect the market? What are companies planning with COVID-19 largely endemic? These questions and more are answered in Kalorama's Clinical Laboratory Services report. laboratories are the workhorse of diagnostic services for the...Published: June 17, 2020 | Price: $6,000.00 – $12,000.00
Kalorama Information's report provides a comprehensive market analysis and business planning tool for the market for tests that are aligned with a pharmaceutical treatment. Especially in oncology, companion diagnostics are rising to the forefront of pharmaceutical development and treatment. Companion diagnostics increase the probability of clinical success by identifying patients with the presence of biomarkers or disease-specific therapeutic targets that can dramatically improve outcomes. Companion diagnostics can also decrease costs by identifying the patient population that will most likely benefit...Published: October 31, 2019 | Price: $3,000.00 – $6,000.00
This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China Genetic Testing New POC Innovations Cancer Testing and Personalized Medicine Hematology Glucose Monitoring Advancements HbA1c Testing New Developments in Infectious Diseases Cytology - Increasing Molecular Dx Options...Published: July 1, 2007 | Price: $995.00 – $3,990.00
In light of laboratory pressures to do more with less, laboratory managers transfer cost control onto vendors by means of a constant push for price reductions. In this commercial climate, efficient management of customer and technical service extras is critical. Expertise in managing service offerings will help companies offer service programs that are just enough to differentiate them from the competition. Service programs that offer too much may result in revenue loss. Programs that are perceived to be inadequate place...Published: May 1, 2009 | Price: $250.00 – $1,600.00
The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama's lead analyst, Shara Rosen. Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The...Published: September 7, 2017 | Price: $2,400.00 – $4,800.00
This report takes a look at both prevention procedures such as sterilization and surface area disinfection and testing such as molecular tests and immunoassays. Infection control in healthcare facilities deals largely with protecting building occupants from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of healthcare is known as a nosocomial, or hospital acquired, infection. What...Published: May 19, 2020 | Price: $5,000.00 – $10,000.00
Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets. Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential (or 3-part differential), manual differential/review, hematocrit, hemoglobin (automated, manual), sedimentation rate, reticulocyte count, white blood cell (WBC) count, platelet count and analysis, and red blood...Published: October 25, 2017 | Price: $3,600.00 – $7,200.00
HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) Kalorama Information’s HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC]) provides market size and growth of the global HIV testing market, including: Global HIV Testing Market, 2015-2022 (in millions at manufacturer level) Global HIV Testing Market Share Percent by Test Category, 2017 (%; Lab-based, Molecular, POC) Global HIV Testing Market Share Percent by Test Category, 2022 (%; Lab-based, Molecular, POC) The three categories of the global HIV testing market – lab-based immunoassay HIV testing,...Published: December 6, 2017 | Price: $1,200.00 – $2,400.00
Human Microbiome Applications in IVD and Other Healthcare Human Microbiome Applications in IVD and Other Healthcare examines the growing interest in the human microbiome in in vitro diagnostics and other healthcare applications. This report notes IVD company interest in the microbiome, including selected microbiome-based tests, including selected molecular tests; microbiome-based diagnostic biomarkers; and precision or personalized medicine approaches to the microbiome. Human Microbiome Applications in IVD and Other Healthcare notes pharmaceutical company interest in the microbiome as well. Discussed are...Published: September 6, 2017 | Price: $3,600.00 – $7,200.00
Immunoassay Markets (Infectious Disease, Tumor Markers, Thyroid, Allergy, Drugs of Abuse, Therapeutic Drug Monitoring, Others) This report, from Kalorama Information, the premier market research publisher in in vitro diagnostics, features the following market data: Global Immunoassay Market, 2017-2021 Historical Market 2014-2016 ELISA Markets Radioimmunoassay Markets Lab-baded Immuonassay Markets POC Immumonassays Infectious Disease Immunoassays - (Hepatitis, HIV, STD, TORCH, Respiratory, HAIs, Other Infectious Disease) Tumor Marker Immunoassays Thyroid Metabolic and Other Hormone Immunoassays Therapeutic Drug Monitoring Immunoassays Drugs of Abuse Immunoassays...Published: May 1, 2009 | Price: $250.00 – $3,395.00
It is commonly asserted that in vitro diagnostics is a recession-proof industry. Kalorama Information's lead diagnostic analyst Shara Rosen tests that assumption and provides strategic conclusions in Shara Rosen's new report In Vitro Diagnostics in a Recessionary Economy. The economic problems that began slowing the U.S. economy keep spreading, with Europe and Japan following America into recession. The US is experiencing high unemployment rate and increased numbers of uninsured workers. But what impact is the downturn having on in vitro...Published: October 12, 2017 | Price: $4,796.00 – $9,600.00
Published: April 7, 2022 | Price: $6,000.00 – $12,000.00
The Most Comprehensive and Reliable Market Sizing and Forecasts in Infectious Disease IVD [caption id="attachment_18836" align="aligncenter" width="300"] Attend a WEBINAR on this topic.[/caption] Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the...Published: February 26, 2018 | Price: $5,500.00 – $11,000.00
Infectious Disease Testing: World Market Analysis (HIV, Hepatitis, Blood Screening With over 400 tables to illustrate the analysis and provide solid business planning metrics, The World Market for Infectious Disease Diagnostic Diagnostics Testing, covers 30 areas of infectious diseases in 25 countries and regions. Diseases and technology categories segmented and forecasted in this report include: Blood Screening Immunoassay Blood Screening NAT Influenza Tests Strep A Test RSV Testing Malaria Tests Dengue Testing HIV Tests – Laboratories HIV Tests – POC...Published: April 30, 2019 | Price: $5,500.00 – $11,000.00
Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Most of the leading industry competitors as well as a sizable number of specialized IVD concerns are active in this product segment. The detection and characterization of infectious diseases hold promising worldwide growth potential as discussed in Kalorama’s Infectious Disease Diagnostics: World Market Analysis: HIV/AIDS, Hepatitis, Tuberculosis, STDs, HAIs, ID/AST, Influenza, TORCH, Other. The World Infectious Disease Testing Market...Published: August 5, 2013 | Price: $2,500.00 – $5,000.00
This report, IVD in China represents Kalorama's complete analysis on the Chinese IVD market. The report provides an introduction to the healthcare system in China, the results of recent reform efforts, and issues and trends. Regional breakouts of the Chinese system are provided. The report describes the role that out-of-pocket expenditures and private concerns play in the delivery of healthcare in the nation. The modern Chinese healthcare market was borne of and continues to be guided by the progressive intentions...Published: April 12, 2018 | Price: $3,995.00 – $7,990.00
IVD in China As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. This report provides the following market data: Market by Province (Guangdong, Shangdong, Henan, Sichuan, Jiangsu, Hebei, Hunan, Anhui, Zhejiang,...Published: June 11, 2015 | Price: $1,995.00 – $3,995.00
IVD in China Market Outlook 2014-2024 With a population of more than 1 billion, China is the world’s largest country and therefore also its single largest potential market for goods and services. In the past ten years, China has led all major world economies in the average rate of growth in real GDP, total health expenditures, and government health expenditures. As an in vitro diagnostics (IVD) market, China trails only the populous, developed markets of the United States, western European countries,...